HZNP - Horizon Pharma Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue981,120757,044296,955
Cost of Revenue393,272219,50278,753
Gross Profit587,848537,542218,202
Operating Expenses
Research Development60,70741,86517,460
Selling General and Administrative608,308440,305209,233
Non Recurring66,00066,00066,000
Others---
Total Operating Expenses---
Operating Income or Loss-147,16755,372-8,491
Income from Continuing Operations
Total Other Income/Expenses Net5,692-118,184-237,370
Earnings Before Interest and Taxes-141,475-62,812-245,861
Interest Expense86,61069,90023,826
Income Before Tax-228,085-132,712-269,687
Income Tax Expense-61,251-172,244-6,084
Minority Interest---
Net Income From Continuing Ops-166,834-38,092-292,993
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-166,83439,532-263,603
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-166,83439,532-263,603